Business Description
Nextage Therapeutics Ltd
ISIN : IL0004330119
Compare
Compare
Traded in other countries / regions
NXTG.Israel IPO Date
1993-05-27Description
Nextage Therapeutics Ltd is a holding company. The company, through its subsidiaries, is engaged in the development of biological marker, a molecule/gene, which when present in the body at abnormal levels indicates development of a disease. It is focused on the development and commercialization of cancer diagnostic products.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.07 | |||||
| Equity-to-Asset | -2.65 | |||||
| Debt-to-Equity | -0.13 | |||||
| Debt-to-EBITDA | -0.1 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -61.39 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 20.8 | |||||
| 3-Year EBITDA Growth Rate | 53.7 | |||||
| 3-Year EPS without NRI Growth Rate | 53.1 | |||||
| 3-Year FCF Growth Rate | 47.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 74.74 | |||||
| 9-Day RSI | 71.79 | |||||
| 14-Day RSI | 70.56 | |||||
| 6-1 Month Momentum % | -34.63 | |||||
| 12-1 Month Momentum % | -22.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.24 | |||||
| Quick Ratio | 0.24 | |||||
| Cash Ratio | 0.11 | |||||
| Days Sales Outstanding | 37.5 | |||||
| Days Payable | 59.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6 | |||||
| Shareholder Yield % | -5.27 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 25.69 | |||||
| Operating Margin % | -455.14 | |||||
| Net Margin % | -442.81 | |||||
| FCF Margin % | -258.22 | |||||
| ROA % | -357.73 | |||||
| ROIC % | -262.42 | |||||
| ROC (Joel Greenblatt) % | -1890.59 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 26.15 | |||||
| EV-to-EBIT | -5.95 | |||||
| EV-to-EBITDA | -6.59 | |||||
| EV-to-Revenue | 28.22 | |||||
| EV-to-FCF | -10.22 | |||||
| Earnings Yield (Greenblatt) % | -16.79 | |||||
| FCF Yield % | -9.14 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nextage Therapeutics Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₪) | 0.876 | ||
| EPS (TTM) (₪) | -0.13 | ||
| Beta | 0 | ||
| Volatility % | 150.44 | ||
| 14-Day RSI | 70.56 | ||
| 14-Day ATR (₪) | 0.064212 | ||
| 20-Day SMA (₪) | 0.5861 | ||
| 12-1 Month Momentum % | -22.92 | ||
| 52-Week Range (₪) | 0.256 - 1.158 | ||
| Shares Outstanding (Mil) | 31.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nextage Therapeutics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nextage Therapeutics Ltd Stock Events
| Event | Date | Price(₪) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nextage Therapeutics Ltd Frequently Asked Questions
What is Nextage Therapeutics Ltd(XTAE:NXTG)'s stock price today?
The current price of XTAE:NXTG is ₪0.78. The 52 week high of XTAE:NXTG is ₪1.16 and 52 week low is ₪0.26.
When is next earnings date of Nextage Therapeutics Ltd(XTAE:NXTG)?
The next earnings date of Nextage Therapeutics Ltd(XTAE:NXTG) is .
Does Nextage Therapeutics Ltd(XTAE:NXTG) pay dividends? If so, how much?
Nextage Therapeutics Ltd(XTAE:NXTG) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers